Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$51.25 - $79.34 $4.59 Million - $7.11 Million
-89,559 Reduced 36.26%
157,424 $10.1 Million
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $495,027 - $805,662
-10,573 Reduced 4.11%
246,983 $12 Million
Q3 2022

Nov 07, 2022

BUY
$70.55 - $111.58 $4.25 Million - $6.72 Million
60,247 Added 30.53%
257,556 $18.2 Million
Q2 2022

Aug 10, 2022

SELL
$50.24 - $80.48 $2.57 Million - $4.11 Million
-51,061 Reduced 20.56%
197,309 $14 Million
Q1 2022

May 12, 2022

BUY
$57.98 - $93.5 $716,284 - $1.16 Million
12,354 Added 5.23%
248,370 $19.8 Million
Q4 2021

Feb 11, 2022

SELL
$88.02 - $127.79 $342,045 - $496,591
-3,886 Reduced 1.62%
236,016 $22.1 Million
Q3 2021

Nov 10, 2021

SELL
$122.75 - $162.68 $76,473 - $101,349
-623 Reduced 0.26%
239,902 $30.8 Million
Q2 2021

Aug 11, 2021

BUY
$105.76 - $154.96 $25.4 Million - $37.3 Million
240,525 New
240,525 $36.7 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.